Freshfields and Linklaters have advised on Wefen´s, a worldwide leader in specialized diagnostics, 500 million euros five-year senior notes issue. Freshfields has advised Werfen and Linklaters has advised the banks which acted as joint book-running managers for the transaction.
The Freshfields team was led by counsel Joe Amann, with the support of senior associate Chelsey Kaka, associate Javier González Egaña and trainee solicitor Chloe Clavell.
Linklaters team was led by capital markets partner Federico Briano, with the support of managing associate Yiannis Kyriakides and associate Cristina Yanguas Lucena have advised the banks acting as joint lead managers on the transaction.
The bond was issued in the context of Werfen’s recent acquisition of US leader in the transfusion and transplant sectors, Immucor. The bonds are listed on the regulated market of Euronext Dublin.
This is the first bond issue under Werfen’s Euro Medium Term Notes (EMTN) programme, which was established by the company in April 2023 and which represents a strategic milestone for Werfen, enabling it to consolidate its presence in the international capital markets and increase its financial flexibility. In October 2021, Werfen tapped the bond market for the very first time with a successful standalone issue of €300 million.
Freshfields and Linklaters also advised Werfen on its debut issue in 2021 and on the establishment of its EMTN programme.
Image: Top part: Freshfields team. Bottom Part: Linklaters team.